The FDA has accepted for review the New Drug Application for a 25mg oral formulation of semaglutide for chronic weight management.

Learn more › Ready to transform your body before summer? It’s possible with the ShedRx 4-Week Semaglutide Weight Loss Program. It offers personalized care, telehealth consultations ...

After May 22, compounding pharmacies can no longer make and sell semaglutide injections. They were initially allowed to because the FDA declared a shortage, but that period has ended. At Melrose ...

Using semaglutide injections, scientists were able to reverse life-threatening cases of liver disease in a new clinical trial published in The New England Journal of Medicine. Semaglutide ...

The prospect of a pill rather than an injection is obviously appealing to some people, but will fear of needles be enough to ...

Researchers examined 1733 reports of ocular adverse drug events, comprising 1541 and 192 cases related to injectable forms and oral tablets ... both formulations of semaglutide; adverse drug ...

More than half of adults with MASH receiving semaglutide had resolution of steatohepatitis at 72 weeks. A reduction in liver fibrosis stage was observed among 36.8% of the semaglutide group.

However, at the two-year, three-year, and four-year time points from the index date, those taking semaglutide had an increased risk for NAION (hazard ratios, 2.39, 2.44, and 2.05, respectively).

Findings showed a 13.6% reduction in body weight in the semaglutide 25mg group compared with a 2.2% reduction in the placebo group. The Food and Drug Administration (FDA) has accepted for review ...